Publications by authors named "Jason A Konner"

Claim this Profile
H
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B Banks, Jason Chan, Jason A Konner

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial.
Aditi Gupta, Roisin E O'Cearbhaill, Matthew S Block, Erika Hamilton, Jason A Konner

Gynecol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore Denys, Jason A Konner

Int J Gynecol Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
Charles Hsu, Jason A Konner, Mrinal M Gounder

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Z.R. McCaw et al.
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Jason A Konner

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Jason A Konner

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Ryan M Kahn, Govind Ragupathi, Qin C Zhou, Alexia Iasonos, Sara Kravetz, Jason A Konner

Cancer Immunol Immunother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Tiffany Y Sia, Beryl Manning-Geist, Sushmita Gordhandas, Rajmohan Murali, Antonio Marra, Jason A Konner

Int J Gynecol Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractive Shifts and Changes in Corneal Curvature Associated With Antibody-Drug Conjugates.
Julia Canestraro, Malin Hultcrantz, Shanu Modi, Paul A Hamlin, Alexander N Shoushtari, Jason A Konner

Cornea· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Sarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, Colin J R Stewart, Esther Oliva, Jason A Konner

Mod Pathol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.
Edaise M da Silva, Daniel J Fix, Ana Paula Martins Sebastiao, Pier Selenica, Lorenzo Ferrando, Jason A Konner

Mod Pathol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.
Oliver Zivanovic, Dennis S Chi, Qin Zhou, Alexia Iasonos, Jason A Konner

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response to lenvatinib and pembrolizumab in two patients with -mutated endometrial mesonephric-like adenocarcinoma.
Sherry Shen, Maria M Rubinstein, Kay J Park, Jason A Konner, Vicky Makker

Gynecol Oncol Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer.
John Vitarello, Marcus D Goncalves, Qin C Zhou, Alexia Iasonos, Darragh F Halpenny, Jason A Konner

JCSM Clin Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Ying L Liu, Qin C Zhou, Alexia Iasonos, Dennis S Chi, Oliver Zivanovic, Jason A Konner

Int J Gynecol Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
Ying L Liu, Qin C Zhou, Alexia Iasonos, Olga T Filippova, Dennis S Chi, Jason A Konner

Int J Gynecol Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer.
Claire F Friedman, Alexandra Snyder Charen, Qin Zhou, Michael A Carducci, Alexandre Buckley De Meritens, Jason A Konner

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial.
Dmitriy Zamarin, Sven Walderich, Aliya Holland, Qin Zhou, Alexia E Iasonos, Jason A Konner

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer.
Ying L Liu, Pier Selenica, Qin Zhou, Alexia Iasonos, Margaret Callahan, Jason A Konner

JCO Precis Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, Nicole N Boucicaut, Melissa Henson, Jason A Konner

Gynecol Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.
Ying L Liu, Olga T Filippova, Qin Zhou, Alexia Iasonos, Dennis S Chi, Jason A Konner

J Gynecol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Ying L Liu, Qin Zhou, Alexia Iasonos, Vivian N Emengo, Claire Friedman, Jason A Konner

Gynecol Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
Tara E Soumerai, Mark T A Donoghue, Chaitanya Bandlamudi, Preethi Srinivasan, Matthew T Chang, Jason A Konner

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate.
Christian Brand, Ahmad Sadique, Jacob L Houghton, Kishore Gangangari, Jose F Ponte, Jason A Konner

EJNMMI Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
Kathleen N Moore, Lainie P Martin, David M O'Malley, Ursula A Matulonis, Jason A Konner

Future Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis